{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T05:18:56Z","timestamp":1648531136044},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mou.0b013e328361f503","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T10:41:54Z","timestamp":1368182514000},"page":"355-359","source":"Crossref","is-referenced-by-count":0,"title":["Results of hormone therapy as first-line treatment for high-risk prostate cancer"],"prefix":"10.1097","volume":"23","author":[{"given":"Nicolas","family":"Mottet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-12-20210206","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.juro.2008.08.079","article-title":"Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.","volume":"180","author":"White","year":"2008","journal-title":"J Urol"},{"key":"R4-12-20210206","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1464-410X.2011.10760.x","article-title":"Locally advanced prostate cancer: a population-based study of treatment patterns.","volume":"109","author":"Lowrance","year":"2011","journal-title":"BJU Int"},{"key":"R6-12-20210206","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"R7-12-20210206","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1997.15.3.1013","article-title":"Phase III trial of androgen suppression using goserelin in unfavourable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.","volume":"15","author":"Pilepich","year":"1997","journal-title":"J Clin Oncol"},{"key":"R8-12-20210206","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"R9-12-20210206","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: long-term results of phase III RTOG 85-31.","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-12-20210206","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","article-title":"Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.","volume":"26","author":"Horwitz","year":"2008","journal-title":"J Clin Oncol"},{"key":"R11-12-20210206","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer.","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"key":"R12-12-20210206","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.24392","article-title":"Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer: meta-analysis of randomized trials.","volume":"115","author":"Bria","year":"2009","journal-title":"Cancer"},{"key":"R13-12-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2008.08.002","article-title":"A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma.","volume":"35","author":"Shelley","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"R14-12-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7SFUO-3): an open randomized phase III trail.","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"key":"R15-12-20210206","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomized, phase 3 trial.","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet"},{"key":"R16-12-20210206","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2012.03.053","article-title":"Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomized phase III trial.","volume":"62","author":"Mottet","year":"2012","journal-title":"Eur Urol"},{"key":"R19-12-20210206","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1464-410X.2010.09730.x","article-title":"Radical prostatectomy improves progression free and cancer specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen: a confirmatory study.","volume":"107","author":"Steuber","year":"2010","journal-title":"BJU Int"},{"key":"R20-12-20210206","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2009.12.034","article-title":"Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer.","volume":"57","author":"Engel","year":"2010","journal-title":"Eur Urol"},{"key":"R21-12-20210206","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2010.05.027","article-title":"Does local treatment of the prostate in advanced andor lymph node metastatic disease improve efficacy of androgen-deprivation therapy A systematic review.","volume":"58","author":"Verhagen","year":"2010","journal-title":"Eur Urol"},{"key":"R22-12-20210206","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.285.21.2750","article-title":"Cancer screening in elderly patients: a framework for individualized decision making.","volume":"285","author":"Walter","year":"2001","journal-title":"JAMA"},{"key":"R23-12-20210206","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.2010.31.2330","article-title":"Impact of comorbidity on survival among men with localized prostate cancer.","volume":"29","author":"Albertsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"R24-12-20210206","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1200\/JCO.2005.04.7423","article-title":"Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European organization for research and treatment of cancer (EORTC) trial 30891.","volume":"24","author":"Studer","year":"2006","journal-title":"J Clin Oncol"},{"key":"R25-12-20210206","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.eururo.2007.12.032","article-title":"Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).","volume":"53","author":"Studer","year":"2008","journal-title":"Eur Urol"},{"key":"R26-12-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2008.09.008","article-title":"Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumours: Final results of European Organization for the research and treatment of cancer protocol 30846 after 13 years of follow up (a randomized controlled trial).","volume":"55","author":"Schroder","year":"2009","journal-title":"Eur Urol"},{"key":"R27-12-20210206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1464-410X.1997.d01-6840.x","article-title":"The medical research council prostate working party investigators group: immediate versus deferred treatment for advanced prostatic cancer: initial results of the medical research council trial.","volume":"79","year":"1997","journal-title":"Brit J Urol"}],"container-title":["Current Opinion in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOU.0b013e328361f503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:10:01Z","timestamp":1620965401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042307-201307000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mou.0b013e328361f503","relation":{},"ISSN":["0963-0643"],"issn-type":[{"value":"0963-0643","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}